NSE - Free Realtime Quote INR

EMCURE PHARMACEUTICALS L (EMCURE.NS)

Compare
1,320.45
-25.30
(-1.88%)
As of 10:59:00 AM GMT+5:30. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Satish Ramanlal Mehta CEO, MD & Executive Director 229.59M -- 1951
Mr. Tajuddin Sabir Shaikh Chief Financial Officer 17.17M -- --
Mr. Samit Satish Mehta President of Operations & Whole-Time Director 33.53M -- 1982
Dr. Mukund Keshao Gurjar Chief Scientific Officer & Whole-Time Director 57.7M -- 1952
Mr. Sunil Rajanikant Mehta Executive Director of Projects & Whole-Time Director 34.45M -- 1963
Ms. Namita Vikas Thapar Executive Director of India Business & Whole-Time Director 45.96M -- 1977
Mr. Chetan Rajendra Sharma Company Secretary & Compliance Officer -- -- 1988
Mr. Naveen Soni Director of Corporate Communications & Public Relations -- -- --
Mr. Vikas Madan Thapar President of Corporate Development, Strategy & Finance 3.71M -- 1976
Mr. Rajesh Nair President of HR -- -- --

EMCURE PHARMACEUTICALS L

Plot No. P-1 and P-2
IT-BT Park, Phase II M.I.D.C. Hinjawadi
Pune, 411057
India
91 20 3507 0033 https://www.emcure.com
Sector: 
Healthcare

Description

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Corporate Governance

EMCURE PHARMACEUTICALS L’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

GUFICBIO.NS Gufic Biosciences Limited
420.40
-2.66%
 
AKUMS.NS AKUMS DRUGS AND PHARMA L
571.20
-1.35%
 
KILITCH.NS Kilitch Drugs (India) Limited
328.95
-0.41%
 
INNOVACAP.BO Innova Captab Limited
1,030.70
-3.75%
 
HESTERBIO.NS Hester Biosciences Limited
2,167.50
-0.23%
 
FDC.NS FDC Limited
468.10
-0.49%
 
BIOFILCHEM.NS Biofil Chemicals and Pharmaceuticals Limited
55.98
+1.01%
 
NOVARTIND.BO Novartis India Limited
905.75
+0.58%
 
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,792.80
-0.71%
 
RPGLIFE.NS RPG Life Sciences Limited
2,095.00
-3.15%